Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Ovarian Epithelial × olaparib × Clear all

Phase

Phase 2 6 Phase 3 2 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 BRCA or HRR+ Mutated Ovarian Cancer Patients 1

Interventions

olaparib 1 niraparib 1 liposomal doxorubicin 1 fluciclovine F-18 1 Paclitaxel 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06121401 2025-09-17

IOLANTHE

Mario Negri Institute for Pharmacological Research

Phase 4 Active not recruiting

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡